Literature DB >> 18814261

Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study.

Olga Garkavenko1, Britta Dieckhoff, Shaun Wynyard, Joachim Denner, Robert B Elliott, Paul L Tan, Margaret C Croxson.   

Abstract

Shortage of human donor organs for transplantation has prompted usage of animals as an alternative donor source. Pigs are the most acceptable candidate animals but issues of xenozoonoses remain. Despite careful monitoring of designated pathogen free pigs there is still a risk that their tissues may carry infectious agents. Thus xenotransplantation requires extensive pre-clinical study on safety of the graft especially for those viruses that are either potentially oncogenic and/or immunosuppressive, or can establish persistent infection. A prospective pig-to-primate islet xenotransplantation study was performed which includes monitoring for potentially xenotic viruses namely porcine endogenous retrovirus (PERV), porcine cytomegalovirus (PCMV), porcine lymphotropic herpesvirus (PLHV), and porcine circovirus (PCV) using both molecular diagnostic-PCR and RT-PCR and serology methods. There was no evidence of pig virus transmission into primate recipients. This preclinical study underlines the information concerning viral safety of islet cell xenograft in pig-to-primate xenotransplantation. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18814261     DOI: 10.1002/jmv.21272

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Retroviral restriction factors and infectious risk in xenotransplantation.

Authors:  Y Meije; R R Tönjes; J A Fishman
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  The origin of porcine endogenous retroviruses (PERVs).

Authors:  Joachim Denner
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

3.  Long-term safety from transmission of porcine endogenous retrovirus after pig-to-non-human primate corneal transplantation.

Authors:  Hyuk Jin Choi; Jiyeon Kim; Jae Young Kim; Hyun Ju Lee; Won Ryang Wee; Mee Kum Kim; Eung Soo Hwang
Journal:  Xenotransplantation       Date:  2017-05-14       Impact factor: 3.907

4.  Encapsulated islets transplantation: Past, present and future.

Authors:  Naoaki Sakata; Shoichiro Sumi; Gumpei Yoshimatsu; Masafumi Goto; Shinichi Egawa; Michiaki Unno
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

5.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

6.  Creation of a Bioengineered Skin Flap Scaffold with a Perfusable Vascular Pedicle.

Authors:  Bernhard J Jank; Jeremy Goverman; Jacques P Guyette; Jon M Charest; Mark Randolph; Glenn R Gaudette; Joshua R Gershlak; Martin Purschke; Emilia Javorsky; Rosalynn M Nazarian; David A Leonard; Curtis L Cetrulo; William G Austen; Harald C Ott
Journal:  Tissue Eng Part A       Date:  2017-06-19       Impact factor: 3.845

Review 7.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Identification and promoter analysis of PERV LTR subtypes in NIH-miniature pig.

Authors:  Yi-Deun Jung; Hong-Seok Ha; Sang-Je Park; Keon-Bong Oh; Gi-Sun Im; Tae-Hun Kim; Hwan-Hoo Seong; Heui-Soo Kim
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

Review 9.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

Review 10.  Immune modulation in xenotransplantation.

Authors:  Magdalena Boksa; Joanna Zeyland; Ryszard Słomski; Daniel Lipiński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-10-30       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.